for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Westlaw News

Novartis sues Mylan over generic version of cancer drug Afinitor

Novartis AG on Friday filed a patent infringement lawsuit seeking to block Mylan Inc from launching a generic version of cancer drug Afinitor.

Basel, Switzerland-based Novartis sued Mylan in federal court in Delaware, alleging the latter company’s proposed generic would infringe on three patents related to Afinitor. Mylan is also seeking a declaration that its patents are invalid.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2nTSBTQ

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up